Procept Biorobotics (PRCT) insider buying

Healthcare · Medical Devices · Market cap $1.2B

3 open-market purchases of PRCT by Procept Biorobotics's executives and directors since March 2026, worth $10M in total, from SEC Form 4 filings.

The most recent: Antal Rohit Desai bought $2M on March 9, 2026.

The biggest buyer over the period is Antal Rohit Desai: 3 purchases, $10M.

By year

YearPurchasesValue
20263$10M

Biggest buyers

InsiderBuysValue
Antal Rohit Desai
3$10M

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Mar 9, 2026 Antal Rohit Desai
98,699$24.55$2M Form 4
Mar 6, 2026 Antal Rohit Desai
160,317$23.59$4M Form 4
Mar 5, 2026 Antal Rohit Desai
167,246$25.58$4M Form 4
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for PRCT.
Open PRCT in Investingly

Questions

Are Procept Biorobotics insiders buying the stock?

3 open-market purchases of PRCT by Procept Biorobotics's executives and directors since March 2026, worth $10M in total, from SEC Form 4 filings. The most recent: Antal Rohit Desai bought $2M on March 9, 2026.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Procept Biorobotics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.